LifeScience Biologics

Illumina and HaploX Collaborate on Benchtop Sequencing System

This marks a new stage in the strategic partnership between the two companies. In the future, Illumina and HaploX will take the localized manufacturing of ...

 December 13, 2023 | News

Inside the World of Cell Therapies: Illuminating the Future of Cancer Care

The Rise of Cell Therapies in Cancer Care Recent years have witnessed significant strides in the development and application of cell therapies for cancer ...

 December 13, 2023 | News

CSL Behring's HEMGENIX® Shows Long-Term Durability and Safety in Hemophilia B

HEMGENIX® is the first and only gene therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of he...

 December 12, 2023 | News

Whole Exome Sequencing Advancements in Unraveling Rare Diseases in Japan

The Rare Disease Diagnosis and Intractable Disease Research Center at Juntendo University has improved its diagnostic capabilities by combining research ...

 December 11, 2023 | News

Nona Biosciences Announces Collaboration with Evive Biotech to Accelerate Antibody Discovery

The collaboration brings together professional advantages of Nona Biosciences and Evive Biotech, aiming to accelerate the process of antibody discovery and...

 December 11, 2023 | News

FDA Greenlights Groundbreaking Gene Therapies for Sickle Cell Disease Treatment

Sickle cell disease is a group of inherited blood disorders affecting approximately 100,000 people in the U.S. It is most common in African Americans and, ...

 December 08, 2023 | News

CRISPR Explores Future of Cell & Gene Therapy at 2024 GenScript Biotech Global Forum

Recently, the world's first CRISPR/Cas9 gene editing therapy received market approval in the UK. This significant achievement comes 11 years after the inve...

 December 08, 2023 | News

Innovent Biologics and Synaffix Expand ADC Collaboration Amid Promising Phase 1 Results

The expanded deal builds on a previous agreement signed in June 2021, under which Innovent is granted to deploy Synaffix's ADC technologies on a targe...

 December 07, 2023 | News

Biotium Launches New Line of Extensively Validated Primary Antibody Conjugates for Flow Cytometry

Biotium, a leading provider of innovative solutions for life science research, is thrilled to announce the launch of Biotium Choice primary antibody conjug...

 December 06, 2023 | News

Nona Biosciences Announces Collaboration Agreement with Lycia Therapeutics

Lycia is using its proprietary lysosomal targeting chimeras (LYTACs) platform to discover and develop first-in-class therapeutics that degrade extracellula...

 December 05, 2023 | News

FDA Clears CARsgen's CT071 for Relapsed/Refractory Multiple Myeloma

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignan...

 December 05, 2023 | News

China Pharma Completes Third-Party Testing for Dry Eye Therapeutic Device

According to a disclosure by the Shanghai Public Health Clinical Center on June 6, 2023, an epidemiological survey of DED showed that approximately 34...

 November 30, 2023 | News

Bahrain Secures Latest Human Genome Sequencing Machine in the Middle East

The Chairman of the Supreme Council of Health, Lt. General Dr. Shaikh Mohammed bin Abdulla Al Khalifa, highlighted the ongoing efforts within the Nati...

 November 30, 2023 | News

Merck Expands Newest Biologics Testing Center in Shanghai

Further develops its biosafety testing laboratories to meet local demand New labs complete 2nd phase of company’s € 29 million...

 November 30, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close